Values as of: 2024-09-18
COMMON STOCK | Insurance Brokers |
Last Closing
USD 1.32Change
-0.01 (-0.75)%Market Cap
USD 0.07BVolume
0.22MAnalyst Target
USD 22.50Verdict
Verdict
Fanhua Inc., together with its subsidiary, distributes insurance products in China. It operates through two segments, Insurance Agency and Claims Adjusting. The Insurance Agency segment provides life and health insurance products, such as individual whole life, individual health, individual annuity, individual term life, individual endowment life, and participating insurance products; and non-life insurance products primarily includes individual accident, travel, homeowner, indemnity medical, commercial property, cargo, hull, liability, construction and erection, and extended warranty insurance products. The Claims Adjusting segment offers pre-underwriting survey, claims adjusting, residual value disposal, loading and unloading supervision, and consulting services. The company also provides value-added services; elderly care services; healthcare services; and family governance services. In addition, it operates Baowang (baoxian.com), an online insurance distribution platform; Lan Zhanggui, an all-in-one insurance sales and service platform; FA app, an all-in-one insurance sales and service platform; ehuzhu.com, an online mutual aid platform; Fanhua RONS DOP, a digital marketing platform; Fanhua RONS Guanjia, a customer service platform; and Fanhua WeCom that enables agents to directly interact with existing and potential customers. The company serves customers through insurance sales and service group, and insurance agencies, as well as sales and service outlets, independent sales agents, and in-house claims adjustors. The company was formerly known as CNinsure Inc. and changed its name to Fanhua Inc. in December 2016. Fanhua Inc. was founded in 1998 and is headquartered in Guangzhou, China. Fanhua Inc. operates as a subsidiary of Highest Performances Holdings Inc.
Company Website : https://www.fanhuaholdings.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| ERIE | Erie Indemnity Company |
+11.22 (+2.14%) |
USD 27.24B |
| CRVL | CorVel Corp |
+0.39 (+0.12%) |
USD 5.43B |
| BWIN | The Baldwin Insurance Group, I.. |
+1.30 (+2.65%) |
USD 3.22B |
| GOCO | GoHealth Inc. |
+0.39 (+4.25%) |
USD 0.20B |
| EHTH | eHealth Inc |
-0.14 (-3.37%) |
USD 0.11B |
| HUIZ | Huize Holding Ltd |
N/A |
USD 0.04B |
| RELIW | Reliance Global Group Inc |
N/A |
USD 0.04B |
| TIRX | Tian Ruixiang Holdings Ltd |
+0.02 (+1.04%) |
USD 4.03M |
| RELI | Reliance Global Group Inc |
-0.10 (-3.70%) |
USD 3.42M |
| TWFG | TWFG, Inc. Class A Common Stoc.. |
+0.44 (+1.61%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| HAO | Haoxi Health Technology L.. | 0.00 % | 0.63 % |
+0.17 (+6.01%) |
N/A |
| Market Performance vs. Industry/Classification (Insurance Brokers) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -80.15% | 10% | F | 5% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -80.15% | 10% | F | 5% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -82.04% | 20% | F | 7% | C- | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -82.04% | 20% | F | 7% | C- | ||
| Trailing 5 Years | |||||||
| Capital Gain | -95.23% | 20% | F | 7% | C- | ||
| Dividend Return | 8.49% | 50% | F | 31% | F | ||
| Total Return | -86.74% | 60% | D- | 12% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | -25.85% | 40% | F | 13% | F | ||
| Dividend Return | -23.08% | 40% | F | 15% | F | ||
| Total Return | 2.77% | 100% | F | 62% | D | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 37.16% | 90% | A- | 50% | F | ||
| Risk Adjusted Return | -62.10% | 30% | F | 15% | F | ||
| Market Capitalization | 0.07B | 50% | F | 32% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
This stock has shown below median revenue growth in the previous 5 years compared to its sector
